CSL reports massive earnings, agrees to buy US plasma business Talecris [ + ]

Pharmaxis concludes dose study of Bronchitol in cystic fibrosis patients [ + ]

Researchers answer brain tumour 'cell of origin' question [ + ]

CogState wins $1.2 million technology contract [ + ]

Acrux expands partnership agreement with KV Pharmaceuticals [ + ]

Cochlear records 15% profit growth [ + ]

Mesoblast's stem cells able to regenerate damaged knee cartilage [ + ]

New funding announced in Victorian innovation statement [ + ]

Professor Ian Chubb AC has been appointed as a part-time member of the CSIRO Board.

Tissue Therapies begins first trial in patient with venous ulcer [ + ]

Biota begins dosing in early stage cold preventative [ + ]

Virax gets approval for early phase trial of HIV vaccine in South Africa [ + ]

A facility dedicated to the production of monoclonal antibodies which can be used for research into cardiovascular disease, neurological disorders, inflammation, brain diseases and cancer has opened in Melbourne. The Monoclonal Antibody Technologies Facility comes from collaboration between the Commonwealth and Victorian governments and Monash University.

A new grants program linking NSW and South Korea in joint technology projects has been announced. Preliminary applications for the grants will close on 30 September and final applications on 15 November.

NMR is being used to non-invasively map the layers of paint in old masterpieces.